- Home
- BBAI vs SUPN Comparison
BBAI vs SUPN Comparison
Compare BBAI & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAI
- SUPN
- Stock Information
- Founded
- BBAI 2020
- SUPN 2005
- Country
- BBAI United States
- SUPN United States
- Employees
- BBAI N/A
- SUPN N/A
- Industry
- BBAI EDP Services
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- BBAI Technology
- SUPN Health Care
- Exchange
- BBAI Nasdaq
- SUPN Nasdaq
- Market Cap
- BBAI 2.9B
- SUPN 2.6B
- IPO Year
- BBAI N/A
- SUPN 2012
- Fundamental
- Price
- BBAI $6.80
- SUPN $44.92
- Analyst Decision
- BBAI Strong Buy
- SUPN Strong Buy
- Analyst Count
- BBAI 2
- SUPN 4
- Target Price
- BBAI $7.00
- SUPN $63.25
- AVG Volume (30 Days)
- BBAI 140.8M
- SUPN 1.0M
- Earning Date
- BBAI 11-10-2025
- SUPN 11-04-2025
- Dividend Yield
- BBAI N/A
- SUPN N/A
- EPS Growth
- BBAI N/A
- SUPN N/A
- EPS
- BBAI N/A
- SUPN N/A
- Revenue
- BBAI $144,199,000.00
- SUPN $681,539,000.00
- Revenue This Year
- BBAI N/A
- SUPN $8.29
- Revenue Next Year
- BBAI $13.83
- SUPN $22.72
- P/E Ratio
- BBAI N/A
- SUPN N/A
- Revenue Growth
- BBAI N/A
- SUPN 4.54
- 52 Week Low
- BBAI $1.65
- SUPN $29.16
- 52 Week High
- BBAI $10.36
- SUPN $57.65
- Technical
- Relative Strength Index (RSI)
- BBAI 52.84
- SUPN 36.31
- Support Level
- BBAI $5.29
- SUPN $44.47
- Resistance Level
- BBAI $6.21
- SUPN $46.59
- Average True Range (ATR)
- BBAI 0.53
- SUPN 2.54
- MACD
- BBAI -0.05
- SUPN -1.24
- Stochastic Oscillator
- BBAI 73.22
- SUPN 13.14
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment. Company generate revenue by providing customers with Edge AI-powered decision intelligence solutions and services for data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics and predictive visualization. It generate revenue from providing both software and services to customers.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.